NASDAQ:SGEN
Delisted
Seattle Genetics Stock News
$228.74
+0 (+0%)
At Close: Mar 12, 2024
Top Stocks In Multiple Industries Build Bases As Market Gains Strength
03:01pm, Friday, 02'nd Dec 2022
An array of top stocks in a wide variety of industries are building cup bases as the stock market recovers. The post Top Stocks In Multiple Industries Build Bases As Market Gains Strength appeared fir
2 Growth Stocks to Buy if the Bear Market Continues in 2023
02:53pm, Thursday, 01'st Dec 2022 The Motley Fool
These stocks aren't bargain buys just yet, but they could be soon.
These Are the Five Best and Worst Performing Healthcare Stocks in October 2022
08:02pm, Monday, 28'th Nov 2022
The healthcare sector has gained momentum following the COVID-19 pandemic. Several companies gained early regulatory approval for developing COVID-19 drugs and distributing vaccines.
Hot Biotech Stocks Rise Into Leadership; Pass Buy Points Or Build Bases
02:10pm, Friday, 25'th Nov 2022
Top biotech stocks surge within the IBD 50. Some pass buy points while others build bases.
Expert Ratings for Seagen
01:01pm, Monday, 21'st Nov 2022 Benzinga
Over the past 3 months, 12 analysts have published their opinion on Seagen (NASDAQ:SGEN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company
The Zacks Analyst Blog Highlights Merrimack Pharmaceuticals, Moderna and Seagen
11:56am, Thursday, 17'th Nov 2022 Zacks Investment Research
Highlights Merrimack Pharmaceuticals, Moderna and Seagen are included in this Analyst Blog.
Biotech Stock Roundup: MACK Up on Study Data, MRNA Offers Vaccine Update & More
04:28pm, Wednesday, 16'th Nov 2022 Zacks Investment Research
Pipeline updates from MACK and MRNA are the key highlights from the biotech sector during the past week.
Did You Buy And Not Sell Friday? You're Doing It Wrong - Again
08:33am, Monday, 14'th Nov 2022 Seeking Alpha
This week saw quite a bit of volatility yet the VIX continues to fall. Read more to see why I expect this week we will see quite a comedown.
Seagen (SGEN) Adcetris Label Expansion OK'd, New CEO Named
03:23pm, Friday, 11'th Nov 2022 Zacks Investment Research
The FDA approves Seagen's (SGEN) Adcetris for a new indication, treating pediatric patients with previously untreated high-risk Hodgkin lymphoma. The company also appoints a new CEO.
Seagen (SGEN) Adcetris Label Expansion OK'd, New CEO Named
12:02pm, Friday, 11'th Nov 2022
The FDA approves Seagen's (SGEN) Adcetris for a new indication, treating pediatric patients with previously untreated high-risk Hodgkin lymphoma. The company also appoints a new CEO.
Biogen, Seagen Name New CEOs — But One Biotech Stock Crumbles
10:40am, Thursday, 10'th Nov 2022
Biogen and Seagen tapped new CEOs on Thursday but the biotech stocks diverged following the long-anticipated announcements. The post Biogen, Seagen Name New CEOs — But One Biotech Stock Crumbles app
Final Trades: Honeywell, XPO Logistics, Seagen & more
02:18pm, Monday, 31'st Oct 2022
The "Halftime Report" traders give their top picks to watch for the second half.
Seagen's (SGEN) Q3 Earnings Miss, Revenues Surpass Estimates
01:18pm, Friday, 28'th Oct 2022 Zacks Investment Research
Seagen (SGEN) reports a wider-than-expected loss in the third quarter of 2022 while its revenues beat estimates. The company raises total revenue guidance for 2022.
Seagen Inc. (SGEN) Q3 2022 Earnings Call Transcript
06:30am, Friday, 28'th Oct 2022 The Motley Fool
SGEN earnings call for the period ending September 30, 2022.
Seagen Inc. (SGEN) Q3 2022 Earnings Call Transcript
09:30pm, Thursday, 27'th Oct 2022
Seagen Inc. (NASDAQ:SGEN ) Q3 2022 Earnings Conference Call October 27, 2022 4:30 PM ET Company Participants Doug Maffei - Vice President, Investor Relations Roger Dansey - Interim Chief Executive Off
